Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)
Posted Date: May 15, 2019
- Investigator: Aram Zabeti
- Type of Study: Drug
Consonance MN39159
Criteria:
-Have A Definite Diagnosis Of Rrms, As Per The Revised Mcdonald 2010 Criteria -Have A Length Of Dis
Keywords:
Ocrelizumab , Relapsing Remitting
For More Information:
Molly Winters
513-558-0269
molly.winters@uc.edu